update RLG Publicizes MDL Consolidation of Lawsuits Over Biomet M2A Metal-On-Metal Hips

The Rottenstein Law Group, which represents clients with claims for injuries allegedly stemming from hip replacement devices manufactured and sold by various companies, has learned that a significant number of lawsuits over a model of Biomet hip implants have been consolidated in a federal court in Indiana.

The U.S. Judicial Panel on Multidistrict Litigation (JPML) this week moved 65 pending cases over personal injuries allegedly caused by Biomet’s M2A Magnum metal-on-metal hip implants from other jurisdictions to the U.S. District Court for Northern Indiana, according to the Oct. 3, 2012, edition of MassDevice.

According to MassDevice, the JPML consolidated the cases over objections from Biomet, whose lawyers argued that the trials should be relocated to New York or New Jersey, contending in court documents that “individualized, plaintiff-specific issues will predominate among the actions” and filing court documents arguing that the cases are inappropriate for centralization because the M2A Magnum hip implant hasn’t been recalled, several other cases alleging injuries stemming from that device have already been resolved, and the M2A device “has been comparatively less problematic than similar hip implant products of its competitors.”

As the representative of claimants allegedly injured by several brands of metal-on-metal hip implants, the Rottenstein Law Group supports the JPML’s consolidation of cases over injuries allegedly caused by hip implants to the extent that such consolidations simplify case management, expedite discovery, and ensure the presiding judge has a long-term understanding of the facts at hand.

Join the Discussion

Please note: Comments are encouraged in order to permit visitors to discuss relevant topics. Comments are moderated and might be edited by RLG before being published.

Comments should not be used to ask questions of RLG’s lawyers; if you want to speak with a lawyer, please fill out this contact form or call 1 (888) 976-8529. *Your name and email address will not be published.



RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.